Join
Live feed
·
INSIDERFilingvia Quantisnow
Angion Biomedica Corp. logo

SEC Form 4: Goldberg Itzhak sold $107,721 worth of shares (32,118 units at $3.35) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,720,068 units

ByQuantisnow·Wall Street's wire, on your screen.
ANGN· Angion Biomedica Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANGN (Angion Biomedica Corp.) and more on Quantisnow.